Cited by 1,192Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Friberg, Leif, Rosenqvist, Mårten, Lip, Gregory Y.H.·2012·European Heart Journal

DOI 10.1093/eurheartj/ehr488

Open this paper in CoChat — free account

Abstract

Aims The impact of some risk factors for stroke and bleeding, and the value of stroke and bleeding risk scores, in atrial fibrillation (AF), has been debated, as clinical trial cohorts have not adequately tested these. Our objective was to investigate risk factors for stroke and bleeding in AF, and application of the new CHA(2)DS(2)-VASc and HAS-BLED schemes for stroke and bleeding risk assessments, respectively. Methods and results We used the Swedish Atrial Fibrillation cohort study, a nationwide cohort study of 182 678 subjects with a diagnosis of AF at any Swedish hospital between 1 July 2005 and 31 December 2008, who were prospectively followed for an average of 1.5 years (260 000 years at risk). With the use of the National Swedish Drug Registry, all patients who used an oral anticoagulant anytime during follow-up were identified. Most of the analyses were made on a subset of 90 490 patients who never used anticoagulants. Risk factors for stroke, the composite thromboembolism endpoint (stroke, TIA, or systemic embolism), and bleeding, and the performance of published stroke and bleeding risk stratification schemes were investigated. On multivariable analysis, significant associations were found between the following 'new' risk factors and thromboembolic events; peripheral artery disease [hazard ratio (HR) 1.22 (95% CI 1.12-1.32)], 'vascular disease' [HR 1.14 (1.06-1.23)], prior myocardial infarction [HR 1.09 (1.03-1.15)], and female gender [HR 1.17 (1.11-1.22)]. Previou…

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehr488

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citation
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,954
Self-citation
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
Self-citation
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina, R. B. D'Agostino Sr, R. B. D'Agostino Jr, R. S. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929)
Greenland, P. (2007) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.024 · Cited by 1,077
Self-citation

Show all 48 references

Research works printed but not linked: 2

Atrial Fibrillation Investigators, 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomised clinical trials, Arch Intern Med, 154, 1949
National Collaborating Centre for Chronic Conditions, 2006, Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care

Sorted by citations

Items 201–300 of 999

Asian strategy for stroke prevention in atrial fibrillation
Chiang, C., Wang, K.-L., & Lin, S. (2015) · EP Europace · doi:10.1093/europace/euv231 · Cited by 51
Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation
Benz, A. P., Hijazi, Z., Lindbäck, J., Connolly, S. J., Eikelboom, J. W., Oldgren, J., Siegbahn, A. G., & Wallentin, L. C. (2021) · Circulation · doi:10.1161/circulationaha.120.053100 · Cited by 54
Perioperative challenges of atrial fibrillation
Philip, I., Berroëta, C., & Leblanc, I. (2014) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000070 · Cited by 50
Impact of Device Implant Depth After Left Atrial Appendage Occlusion
Guillén, P. L. C., Flores‐Umanzor, E., Leduc, N., Bajoras, V., Perrin, N., Farjat-Pasos, J. I., McInerney, A., Laffond, A. E., Millán, X., Zendjebil, S., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.05.045 · Cited by 50
Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: A cohort study
Saliba, W., Barnett‐Griness, O., Elias, M. S., & Rennert, G. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.01.025 · Cited by 52
Clinical Predictive Models of Sudden Cardiac Arrest: A Survey of the Current Science and Analysis of Model Performances
Carrick, R. T., Park, J. G., McGinnes, H. L., Lundquist, C. M., Brown, K., Janes, W., Wessler, B. S., & Kent, D. M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.017625 · Cited by 50
Serum neurofilament light in atrial fibrillation: clinical, neuroimaging and cognitive correlates
Polymeris, A. A., Coslovsky, M., Aeschbacher, S., Sinnecker, T., Benkert, P., Kobza, R., Beer, J. H., Rodondi, N., Fischer, U., Moschovitis, G., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa166 · Cited by 49
Atrial Fibrillation and Stroke
Essa, H., Hill, A. M., & Lip, G. Y. H. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.11.003 · Cited by 53
Self-citation
Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation
Papazoglou, Α. S., Κάρτας, Α., Moysidis, D. V., Tsagkaris, C., Papadakos, S. P., Bekiaridou, Α., Samaras, A., Karagiannidis, E., Papadakis, M., & Giannakoulas, G. A. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01473-0 · Cited by 51
Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States
Price, M. J., Slotwiner, D. J., Du, C., Freeman, J. V., Turi, Z. G., Rammohan, C., Kusumoto, F. M., Kavinsky, C. J., Akar, J. G., Varosy, P. D., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.02.009 · Cited by 49
Cardiac MRI assessment of atrial fibrosis in atrial fibrillation: implications for diagnosis and therapy
Higuchi, K., Akkaya, M., AKOUM, N. W., & MARROUCHE, N. F. (2013) · Heart · doi:10.1136/heartjnl-2013-303884 · Cited by 49
Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
Wisløff, T. F., Hagen, G., & Klemp, M. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0152-z · Cited by 49
Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices
Weise, F. K., Bordignon, S., Perrotta, L., Konstantinou, A., Bologna, F., Nagase, T., Chen, S., Chun, K. R. J., & Schmidt, B. (2018) · EuroIntervention · doi:10.4244/eij-d-17-00901 · Cited by 49
Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: Long-term results of a multicenter study
Mohanty, S., Gianni, C., Trivedi, C. G., Gadiyaram, V. K., Rocca, D. G. D., MacDonald, B. C., Horton, R., Al‐Ahmad, A., Gibson, D. N., Price, M. J., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.08.003 · Cited by 49
Refinement of Ischemic Stroke Risk in Patients with Atrial Fibrillation and CHA2DS2‐VASc Score of 1
Huang, D., ANGUO, L., Yue, W., Yin, L., Tse, H., & Siu, C. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12445 · Cited by 48
Correlation of CHADS2 and CHA2DS2-VASc Scores with Transesophageal Echocardiography Risk Factors for Thromboembolism in a Multiethnic United States Population with Nonvalvular Atrial Fibrillation
Willens, H. J., Gómez-Marı́n, O., Nelson, K. H., DeNicco, A., & Moscucci, M. M. (2012) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2012.11.002 · Cited by 49
Stroke and Bleeding Risk in Atrial Fibrillation
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2014) · Korean Circulation Journal · doi:10.4070/kcj.2014.44.5.281 · Cited by 46
Self-citation
The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines
Macle, L., Cairns, J. A., Andrade, J. G., Mitchell, L. B., Nattel, S., Verma, A., Verma, A., Macle, L., Andrade, J. G., Atzema, C. L., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.06.005 · Cited by 47
Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches?
Lip, G. Y. H., Al‐Khatib, S. M., Cosío, F. G., Banerjee, A., Savelieva, I., Ruskin, J. N., Blendea, D. C., Nattel, S., Bono, J. D., Conroy, J., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001179 · Cited by 48
Self-citation
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Rosei, E., Azizi, M., Burnier, M., Clement, D., Coca, A., de Simone, G., Dominiczak, A. F., et al. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.12.005 · Cited by 57
Self-citation
History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation
Bruere, H., Fauchier, L., Brunet, A. B., Pierre, B., Siméon, E., Babuty, D., & Clémenty, N. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.014 · Cited by 46
Incidence of cerebral thromboembolic events during long-term follow-up in patients treated with transcatheter ablation for atrial fibrillation
Gaïta, F., SARDI, D., Battaglia, A., Gallo, C., Toso, E., Michielon, A., Caponi, D., Garberoglio, L., Castagno, D., & Scaglione, M. (2014) · EP Europace · doi:10.1093/europace/eut406 · Cited by 45
Predictive performance of the CHA2DS2‐VASc rule in atrial fibrillation: a systematic review and meta‐analysis
van Doorn, S., Debray, T. P. A., Kaasenbrood, F., Hoes, A. W., Rutten, F. H., Moons, K. G. M., & Geersing, G. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13690 · Cited by 49
Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data
Reddy, V. Y., Akehurst, R. L., Gavaghan, M. B., Amorosi, S. L., & Holmes, D. R. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011577 · Cited by 46
Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA2DS2VASc scores: experience from the Stockholm region
Forslund, T., Wettermark, B., Wändell, P. E., von Euler, M., Hasselström, J., & Hjemdahl, P. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1739-1 · Cited by 46
Anticoagulation in new-onset postoperative atrial fibrillation: An analysis from the Society of Thoracic Surgeons Adult Cardiac Surgery Database
Riad, F. S., Grau‐Sepulveda, M. V., Jawitz, O. K., Vekstein, A. M., Sundaram, V., Sahadevan, J., Habib, R., Jacobs, J. P., O’Brien, S. M., Thourani, V. H., et al. (2022) · Heart Rhythm O2 · doi:10.1016/j.hroo.2022.06.003 · Cited by 44
Chinese guidelines for the diagnosis and management of atrial fibrillation
Ma, C., Wu, S., Liu, S., & Han, Y. (2024) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14920 · Cited by 48
Pulmonary ridge coverage and device-related thrombosis after left atrial appendage occlusion
Freixa, X., Guillén, P. L. C., Flores‐Umanzor, E., Regueiro, A., Sanchís, L., Fernández-Valledor, A., Brugaletta, S., Carretero, M. J., Vidal, B., Masotti, M., et al. (2021) · EuroIntervention · doi:10.4244/eij-d-20-00886 · Cited by 44
JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Journal of Arrhythmia · doi:10.1002/joa3.12714 · Cited by 41
Predictors of Gastrointestinal Bleeding Among Patients with Atrial Fibrillation After Initiating Dabigatran Therapy
Lauffenburger, J. C., Rhoney, D. H., Farley, J. F., Gehi, A. K., & Fang, G. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1597 · Cited by 43
Recurrent Stroke
Andersen, S. D., Gorst‐Rasmussen, A., Lip, G. Y. H., Bach, F. W., & Larsen, T. B. (2015) · Stroke · doi:10.1161/strokeaha.115.009912 · Cited by 43
Self-citation
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation
Ahmad, Y., Lip, G. Y. H., & Apostolakis, S. Z. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.148 · Cited by 43
Self-citation
Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: The Chin-Shan Community Cohort Study
Lip, G. Y. H., Lin, H., Hsu, H., Su, T., Chen, M.-F., Lee, Y., & Chien, K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.076 · Cited by 43
Self-citation
Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report
Fumagalli, S., Said, S. A., Laroche, C., Gabbai, D., Boni, S., Marchionni, N., Boriani, G., Maggioni, A. P., Musialik-Lydka, A., Sokal, A., et al. (2017) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvx037 · Cited by 42
Self-citation
European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)
Gorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43
Self-citation
Performance of multilabel machine learning models and risk stratification schemas for predicting stroke and bleeding risk in patients with non-valvular atrial fibrillation
Lü, J., Hutchens, R., Hung, J., Bennamoun, M., McQuillan, B., Briffa, T. G., Sohel, F. A., Murray, K., Stewart, J. E., Chow, B. J. W., et al. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106126 · Cited by 43
Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry
Phillips, K. P., Santoso, T. I., Sanders, P., Alison, J., Chan, J. L. K., Pak, H., Chandavimol, M., Steín, K. M., Gordon, N. T., & Razali, O. (2019) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2019.100358 · Cited by 42
Ischemic Stroke in Adults With Congenital Heart Disease: A Population‐Based Cohort Study
Pedersen, M. G., Olsen, M., Schmidt, M., Johnsen, S., Learn, C. P., Laursen, H., & Madsen, N. (2019) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.118.011870 · Cited by 37
Associations of anemia with stroke, bleeding, and mortality in atrial fibrillation: A systematic review and meta‐analysis
Tu, S. J., Hanna‐Rivero, N., Elliott, A. D., Clarke, N., Huang, S., Pitman, B. M., Gallagher, C., Linz, D., Mahajan, R., Lau, D. H., et al. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14898 · Cited by 42
Advances in understanding spontaneous intracerebral hemorrhage: insights from neuroimaging
Wilson, D., Charidimou, A., & Werring, D. J. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.918506 · Cited by 43
Prevalence of atrial fibrillation in intracerebral hemorrhage
Horstmann, S., Rizos, T., Jenetzky, E., Gumbinger, C., Hacke, W., & Veltkamp, R. C. (2013) · European Journal of Neurology · doi:10.1111/ene.12215 · Cited by 42
New anticoagulant treatments to protect against stroke in atrial fibrillation
Potpara, T., Lip, G. Y. H., & Apostolakis, S. Z. (2012) · Heart · doi:10.1136/heartjnl-2012-301841 · Cited by 41
Self-citation
Association between Atrial Fibrillation Incidence and Temperatures, Wind Scale and Air Quality: An Exploratory Study for Shanghai and Kunming
Lu, S., Zhao, Y., Chen, Z., Dou, M., Zhang, Q., & Yang, W. (2021) · Sustainability · doi:10.3390/su13095247 · Cited by 41
Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making
Eckman, M. H., Wise, R. E., Naylor, K., Arduser, L., Lip, G. Y. H., D, B. M. K. M., Flaherty, M. L., Kleindorfer, D., Khan, F., Schauer, D. P., et al. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1019608 · Cited by 41
Self-citation
Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study
Fauchier, L., Chaize, G., Gaudin, A.-F., Vainchtock, A., Rushton-Smith, S. K., & Cotté, F.-E. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.173 · Cited by 41
CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation
Parsons, C. E., Patel, S. I., Cha, S., Shen, W.-K., Desai, S., Chamberlain, A. M., Luis, S. A., Aguilar, M. I., Demaerschalk, B. M., Mookadam, F., et al. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.10.008 · Cited by 42
Anemia and iron deficiency in patients with atrial fibrillation
Hanna‐Rivero, N., Tu, S. J., Elliott, A. D., Pitman, B. M., Gallagher, C., Lau, D. H., Sanders, P., & Wong, C. X. J. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02633-6 · Cited by 47
Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta‐Analysis of Randomized Controlled Trials
Lin, D. S., Lo, H., Huang, K., Lin, T., & Lee, J. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030380 · Cited by 39
Stroke Risk in Atrial Fibrillation: Beyond the CHA2DS2-VASc Score
Jagadish, P. S., & Kabra, R. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1189-6 · Cited by 42
Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
Arnson, Y., Hoshen, M., Senderey, A. B., Reges, O., Balicer, R. D., Leibowitz, M., Tsadok, M. A., & Haim, M. (2020) · Cardiology · doi:10.1159/000504877 · Cited by 43
Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
Chan, Y., Lee, H., Li, P., Liu, J., Chao, T., Wu, L., Chang, S., Yeh, Y., Kuo, C.-T., See, L., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01043-2 · Cited by 41
Self-citation
Left atrial 4D flow cardiovascular magnetic resonance: a reproducibility study in sinus rhythm and atrial fibrillation
Spartera, M., Pessoa-Amorim, G., Stracquadanio, A., Ende, A. V., Fletcher, A. M., Manley, P., Neubauer, S., Ferreira, V. M., Casadei, B., Hess, A. T., et al. (2021) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-021-00729-0 · Cited by 40
Hyperthyroidism Prevalence in China After Universal Salt Iodization
Wang, C., Li, Y., Teng, D., Shi, X., Ba, J., Chen, B., Du, J., He, L., Lai, X., Li, Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651534 · Cited by 40
3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)
Lakkireddy, D., Thaler, D. E., Ellis, C. R., Swarup, V., Gambhir, A., Hermiller, J. B., Nielsen‐Kudsk, J. E., Worthley, S. G., Nair, D. G., Schmidt, B., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.06.022 · Cited by 39
Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2014) · British Journal of General Practice · doi:10.3399/bjgp15x683113 · Cited by 39
Self-citation
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion.
Meier, B., Blaauw, Y., Khattab, A., Lewalter, T., Sievert, H., Tondo, C., & Glikson, M. (2015) · PubMed · doi:10.4244/eijy14m08_18 · Cited by 39
Association Between High-Sensitivity Cardiac Troponin and Risk of Stroke in 96 702 Individuals
Broersen, L. H. A., Stengl, H., Nolte, C. H., Westermann, D., Endres, M., Siegerink, B., & Scheitz, J. F. (2020) · Stroke · doi:10.1161/strokeaha.119.028323 · Cited by 39
Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study
Mitchell, A., Snowball, J. M., Welsh, T. J., Watson, M. C., & McGrogan, A. (2021) · BMC Medicine · doi:10.1186/s12916-021-02067-5 · Cited by 39
Two‐Year Outcomes With a Next‐Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial
Doshi, S. K., Kar, S., Sadhu, A., Horton, R., Osorio, J., Ellis, C. R., Stone, J. E., Shah, M. H., Dukkipati, S. R., Adler, S. W., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.026295 · Cited by 38
5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial
Lakkireddy, D., Ellis, C. R., Thaler, D. E., Swarup, V., Gambhir, A., Hermiller, J. B., Nielsen‐Kudsk, J. E., Worthley, S. G., Nair, D. G., Schmidt, B., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.10.101 · Cited by 38
Thromboembolic Risk Stratification of Patients Hospitalized with Heart Failure in Sinus Rhythm: A Nationwide Cohort Study
Wolsk, E., Lamberts, M., Hansen, M. L., Blanche, P., Køber, L., Torp-Pedersen, C. T., Lip, G. Y. H., & Gislason, G. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.309 · Cited by 38
Self-citation
Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study
Renoux, C., Coulombe, J., & Suissa, S. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw613 · Cited by 38
Hospitalized frail elderly patients – atrial fibrillation, anticoagulation and 12 months’ outcomes
Ekerstad, N., Karlsson, T., Söderqvist, S., & Karlson, B. W. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s159373 · Cited by 38
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies
Renda, G., Patti, G., Lang, I. M., Siller-Matula, J. M., Hylek, E. M., Ambrosio, G., Haas, S. K., & Caterina, R. D. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.004 · Cited by 39
Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists
Sorigué, M., & Miljković, M. D. (2019) · Journal of Oncology Practice · doi:10.1200/jop.18.00592 · Cited by 38
Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk
Yaghi, S. R., Trivedi, T., Henninger, N., Giles, J. A., Liu, A. H.-C., Nagy, M., Kaushal, A., Azher, I., Grory, B. M., Fakhri, H., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25844 · Cited by 38
Atrial fibrillation burden: an update—the need for a CHA2DS2-VASc-AFBurden score
Tiver, K. D., Quah, J. X., Lahiri, A., Ganesan, A. N., & McGavigan, A. D. (2020) · EP Europace · doi:10.1093/europace/euaa287 · Cited by 40
2025 Clinical practice guidelines for Atrial fibrillation and flutter
Golukhova, E. Z., Sp, G., Михайлов, Е. Н., Revishvili, A. S. H., Arakelyan, M. G., Vasilyeva, E. Y., Davtyan, K. V., Drapkina, O. M., Drozdova, L. Y., Станиславовна, К. Е., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6668 · Cited by 44
Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey
Lip, G. Y. H., Dagres, N., Proclemer, A., Svendsen, J. H., Pison, L., & Blomström‐Lundqvist, C. (2012) · EP Europace · doi:10.1093/europace/eus413 · Cited by 37
Self-citation
Management of atrial fibrillation in chronic kidney disease: Double trouble
Nimmo, C., Wright, M. J., & Goldsmith, D. J. A. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.05.010 · Cited by 35
Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes
Jalal, Z., Dinet, M., Combes, N., Pillois, X., Renou, P., Sibon, I., Iriart, X., & Thambo, J. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.09.006 · Cited by 37
Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation
Freeman, J. V., Tabada, G. H., Reynolds, K., Sung, S. H., Liu, T., Gupta, N., & Go, A. S. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.11.034 · Cited by 37
Socioeconomic differences in outcomes after hospital admission for atrial fibrillation or flutter
Hagengaard, L., Andersen, M. P., Polcwiartek, C., Larsen, J. M., Larsen, M. L., Skals, R. K., Hansen, S. M., Riahi, S., Gislason, G., Torp-Pedersen, C. T., et al. (2019) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcz053 · Cited by 38
Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry
Bayer, V., Kotalczyk, A., Kea, B., Teutsch, C., Larsen, P., Button, D. A., Huisman, M. V., Lip, G. Y. H., & Olshansky, B. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023907 · Cited by 37
Self-citation
Identifying Patients at High Risk of Left Atrial Appendage Thrombus Before Cardioversion: The CLOTS‐AF Score
Segan, L. A., Nanayakkara, S., Spear, E., Shirwaiker, A., Chieng, D., Prabhu, S., Sugumar, H., Ling, L., Kaye, D. M., Kalman, J. M., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029259 · Cited by 40
Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study
Fu, E. L., Desai, R. J., Paik, J. M., Kim, D. H., Zhang, Y., Mastrorilli, J. M., Cervone, A., & Lin, K. J. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.08.017 · Cited by 38
Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry
Camm, A. J., Accetta, G., Almahmeed, W. A., Ambrosio, G., Goldhaber, S. Z., Haas, S. K., Janský, P., Kayani, G., Misselwitz, F., Oh, S., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014579 · Cited by 39
Prescription Patterns of Non-Vitamin K Oral Anticoagulants Across Indications and Factors Associated with Their Increased Prescribing in Atrial Fibrillation Between 2012–2015: A Study from the Norwegian Prescription Database
Urbaniak, A. M., Strøm, B. O., Krontveit, R. I., & Svanqvist, K. H. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0476-4 · Cited by 36
Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry
Cruz‐González, I., González-Ferreiro, R., Freixa, X., Gafoor, S. A., Shakir, S., Omran, H., Berti, S. L., Santoro, G., Kefer, J., Landmesser, U., et al. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.02.013 · Cited by 36
Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation
Chan, P., Huang, D., Hai, J. J., Li, W., Yin, L., Chan, E. W., Wong, I. C. K., Lau, C., Chiang, C., Zhu, J., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.09.015 · Cited by 35
The quality of oral anticoagulation in general practice in patients with atrial fibrillation
Mueller, S., Pfannkuche, M., BREITHARDT, G. E., Bauersachs, R. M., Maywald, U., Kohlmann, T., & Wilke, T. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.12.013 · Cited by 35
Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation
Berti, S. L., Pastormerlo, L. E., Rezzaghi, M., Trianni, G., Paradossi, U., Cerone, E., Ravani, M., Caterina, A. R. D., Rizza, A., & Palmieri, C. (2016) · Heart · doi:10.1136/heartjnl-2015-309150 · Cited by 35
Prevalence of atrial fibrillation and stroke risk assessment based on telemedicine screening tools in a primary healthcare setting
de Moraes, E. R. F. L., Cirenza, C., Lópes, R. D., Carvalho, A. C., Guimarães, P. O., Rodrigues, A. A. E., & de Paola, Â. A. V. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.04.024 · Cited by 35
Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies
Ding, W. Y., Harrison, S. L., Gupta, D., Lip, G. Y. H., & Lane, D. A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00054 · Cited by 36
Self-citation
Risk factors for severe bleeding events during warfarin treatment: the influence of sex, age, comorbidity and co-medication
Rydberg, D. M., Linder, M., Malmström, R. E., & Andersen, M. T. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-02856-6 · Cited by 35
Benefit of Anticoagulation Therapy in Hyperthyroidism‐Related Atrial Fibrillation
Chan, P., Hai, J. J., Yeung, C., Lip, G. Y. H., Lam, K. S. L., Tse, H., & Siu, C. (2015) · Clinical Cardiology · doi:10.1002/clc.22427 · Cited by 34
Self-citation
Succinate links atrial dysfunction and cardioembolic stroke
Nelson, S. E., Ament, Z., Wolcott, Z. C., Gerszten, R. E., & Kimberly, W. T. (2019) · Neurology · doi:10.1212/wnl.0000000000006957 · Cited by 34
Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy
Higuchi, S., Kabeya, Y., Matsushita, K., Arai, N., Tachibana, K., Tanaka, R., Kawachi, R., Takei, H., Suzuki, Y., Kogure, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216239 · Cited by 34
Incidence and Predictors of Early Death in Patients Undergoing Percutaneous Left Atrial Appendage Closure
Mesnier, J., Cruz‐González, I., Arzamendi, D., Freixa, X., y, L. N.-F., Peral, V., Caneiro‐Queija, B., Mangieri, A., Trejo‐Velasco, B., Asmarats, L., et al. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.06.012 · Cited by 34
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation
Maarse, M., Seiffge, D. J., Werring, D. J., Boersma, L. V. A., STR-OAC LAAO Group, Macha, K., Takagi, M., Tsivgoulis, G. K., Bonetti, B., Arihiro, S., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.2882 · Cited by 33
Recent Developments in Understanding Epidemiology and Risk Determinants of Atrial Fibrillation as a Cause of Stroke
Ahmad, Y., Lip, G. Y. H., & Lane, D. A. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.03.009 · Cited by 33
Self-citation
Warfarin use and incidence of stroke in Japanese hemodialysis patients with atrial fibrillation
Yodogawa, K., Mii, A., Fukui, M., Iwasaki, Y., Hayashi, M., Kaneko, T., Miyauchi, Y., Tsuruoka, S., & Shimizu, W. (2015) · Heart and Vessels · doi:10.1007/s00380-015-0777-7 · Cited by 33
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study
Genovesi, S., Porcu, L., Rebora, P., Slaviero, G., Casu, G., Bertoli, S. V., Airoldi, F., Buskermolen, M., Gallieni, M. A., Pieruzzi, F., et al. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad221 · Cited by 32
Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation
Kostopoulos, G., & Effraimidis, G. (2024) · European Thyroid Journal · doi:10.1530/etj-23-0254 · Cited by 36
Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease
Lamberts, M., Lip, G. Y. H., Ruwald, M. H., Hansen, M. L., Özcan, C., Kristensen, S. L., Køber, L., Torp-Pedersen, C. T., & Gislason, G. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.039 · Cited by 31
Self-citation
Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project
Guo, Y.-T., Zhang, Y., Shi, X.-M., Shan, Z., Wang, C.-J., Wang, Y.-T., Chen, Y.-D., & Lip, G. Y. H. (2016) · Scientific Reports · doi:10.1038/srep31755 · Cited by 32
Self-citation
Anticoagulation for atrial fibrillation after intracranial hemorrhage
Hawkes, M. A., & Rabinstein, A. A. (2018) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000425 · Cited by 30
Atrial Fibrillation and Cancer Patients: Mechanisms and Management
Madnick, D. L., & Fradley, M. G. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01769-3 · Cited by 32
Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation
Aakre, C. A., McLeod, C. J., Cha, S. S., Tsang, T. S. M., Lip, G. Y. H., & Gersh, B. J. (2013) · Stroke · doi:10.1161/strokeaha.113.002585 · Cited by 32
Self-citation
Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation
Wang, H., Tian, Y., Guo, Y., Wang, Y., & Lip, G. Y. H. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-07-0577 · Cited by 31
Self-citation

Authors: Friberg, L., Rosenqvist, M., & Lip, G. Y. H.
Affiliations: Danderyds sjukhus (SE)
Karolinska Institutet (SE)
Birmingham City Hospital (GB)
Corresponding author: Lip, Gregory Y.H.
ORCID: Friberg, Leif
Lip, Gregory Y.H.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2012-01-13
Volume: 33
Issue: 12
Pages: 1500-1510
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/ehr488
OpenAlex: W2124601103
Cited by: 1,192
References: 48
Citations by year: 2026: 37 · 2025: 60 · 2024: 74 · 2023: 81 · 2022: 112 · 2021: 99 · 2020: 100 · 2019: 99 · 2018: 78 · 2017: 99 · 2016: 75 · 2015: 99 · 2014: 72 · 2013: 68 · 2012: 35
FWCI: 56.38
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: Stockholms Läns Landsting
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: atrial fibrillation, stroke risk stratification, bleeding risk stratification, CHA2DS2-VASc score, HAS-BLED score, thromboembolism, intracranial hemorrhage, risk factors, peripheral arterial disease, oral anticoagulants, thyroid dysfunction, hyperthyroidism, concordance index
MeSH terms: Adult, Aged, Anticoagulants, Atrial Fibrillation, Female, Hemorrhage, Humans, Male, Middle Aged, Risk Factors, Sweden, Thromboembolism, Cohort Studies, Risk Assessment, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks